Insider Transactions in Q3 2020 at Prelude Therapeutics Inc (PRLD)
Insider Transaction List (Q3 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2020
|
David P Bonita |
BUY
Conversion of derivative security
|
Indirect |
8,332,779
+47.39%
|
-
|
|
Sep 29
2020
|
Paul A Friedman |
BUY
Conversion of derivative security
|
Direct |
448,370
+34.68%
|
-
|
|
Sep 29
2020
|
Baker Bros. Advisors LP |
BUY
Open market or private purchase
|
Indirect |
1,578,947
+12.24%
|
$29,999,993
$19.0 P/Share
|
|
Sep 29
2020
|
Baker Bros. Advisors LP |
BUY
Conversion of derivative security
|
Indirect |
8,332,778
+29.9%
|
-
|
|
Sep 29
2020
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
8,332,779
+47.39%
|
-
|
|
Sep 25
2020
|
David P Bonita |
BUY
Open market or private purchase
|
Indirect |
1,236,800
+46.82%
|
$23,499,200
$19.0 P/Share
|
|
Sep 25
2020
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
1,236,800
+46.82%
|
$23,499,200
$19.0 P/Share
|